Disease ⇒ Dyslipidemia {40000533}

Record Keys

Parent:[  ]


Initialisation date:
Other Terms:[  ]

Meta Information

MedDra ID:[  ]
MedDra Level:[  ]
ICD:[  ]
Category:[  ]
Zone:[  ]
Mechanism:[  ]


[  ]

Shared Reference Notes

  • [1.1] [#CVD, #Postprandial lipidemia, #Diabetes Type 2] [#Berberine] [#Probiotic
    - Prob+BBR superior to BBR or Prob alone in improving postprandial total cholesterol (pTC) and low-density lipoprotein cholesterol (pLDLc) levels with decrement of multiple species of postprandial lipidomic metabolites after 3 months follow-up. - This effect was linked to the changes of fecal #Bifidobacterium breve level responding to BBR alone or Prob+BBR treatment. - Four fadD genes encoding long-chain acyl-CoA synthetase > identified in the genome of this B. breve strain, and transcriptionally activated by BBR. - The activation of fadD by BBR could enhance FFA import and mobilization in B. breve and diliminish the intraluminal lipids for absorption to mediate the effect of Prob+BBR on PL.
  • [1.2] [#Metabolic associated fatty liver disease] [#Fibroblast growth factor 21] [#Resistant starch
    - The serum level of FGF21 was found to be significantly reduced after the 4-month RS intervention. - FGF21 > alleviation of dyslipidemia and NAFLD. - circulating FGF21 is paradoxically elevated in individuals with NAFLD > FGF21 resistance in analogy to obesity-associated insulin and leptin resistance. - aberrant FGF21 signaling has been suggested as a key pathological step in the development and progression of NAFLD.
  • [1.3] [#Short Chain Fatty Acid
    - Consumption of green banana biomass seems to exert beneficial effects on intestinal function and potential effects on #Obesity, dyslipidemia, and diabetes. These effects may be related to increased fecal short-chain fatty acid concentrations as a result of type 3 #Resistant Starch present in biomass.
  • [1.4] [#Short Chain Fatty Acid] [#Prebiotic, #Probiotic
    - A 12-week multi-species synbiotic supplementation in patients with dyslipidemia resulted in significant increases in fecal SCFAs including #Acetate, #Butyrate, #Propionate, and #Valerate in the intervention group.

References Notes

[  ]
MetaBiom only uses strictly necessary session cookies to give you the best possible experience on the website. By selecting "Accept essential cookies" you agree to the use of these cookies.